West's Vial2Bag DC Device Receives FDA 510(k) Clearance and CE Mark
West Pharmaceutical Services has received 510(k) clearance of the Vial2Bag DC device from the FDA, and the CE Mark for the European Union.
The Vial2Bag DC device is produced by West's subsidiary, Medimop Medical Projects and is a universal admixture device designed to enable safe, convenient, needle-free reconstitution and transfer of drug products between a vial and a standard IV bag or bottle. The device connects to the IV bag set port using a standard IV spike and can be used with all standard manufacturers' bags. Following transfer of liquid from the bag, the reconstituted drug is then transferred from the vial back into the bag.
"Intravenous infusions are one of the most universally used methods of administration in healthcare settings. Our new Vial2Bag DC device simplifies the IV admixture process and eliminates the risk of needlestick injuries and minimises potential drug exposure, making this procedure safer and more efficient for healthcare staff," said John Paproski, President, Pharmaceutical Delivery Systems, West Pharmaceutical Services. "This 510(k) clearance and CE Marking extends West's leading portfolio of needle-free reconstitution and transfer devices and will complement the currently marketed Vial2Bag and Vial Adapter devices."
The device is available for 13-mm and 20-mm diameter vials, fits all standard IV bags and is ideal for point-of-care reconstitution and admixture and can assist in compliance with the immediate use provision of USP < 797 >. Progressive Medical Inc. (PMI) will distribute the Vial2Bag DC device to hospitals in the US.
"PMI is a leading distributor of specialty medical products that focuses on high-quality products that help improve patient safety and streamline hospital procedures. They have been successful with the Vial2Bag device over the past three years, which makes the company an excellent choice to distribute the innovative Vial2Bag DC device," said Mr Paproski.
Mark Martin, President and CEO of Progressive Medical Inc., said, "At PMI, our mission is to identify innovative new products that can improve the quality of patient healthcare, so we are very excited about the launch of Vial2Bag DC, because of its potential to improve patient outcomes, and at the same time, streamline and lessen costs in the healthcare system."
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance